Plain-English translation of NCT03192267 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Rheumatoid Arthritis research guide โThis research study is looking at lung disease in people who have recently been diagnosed with rheumatoid arthritis. About half of all rheumatoid arthritis patients develop problems outside their joints, especially in the lungs. The study will collect imaging scans, breathing tests, and blood samples to understand which patients are most likely to develop lung complications and to identify a special blood marker that might predict these problems.
Doctors know that rheumatoid arthritis can affect the lungs, but they don't have good ways to predict who will develop lung problems or how to catch them early. This study aims to find a blood test that could warn patients and their doctors about lung involvement before serious damage occurs.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
As a participant, you would donate blood samples and allow researchers to access your medical records and imaging scans (like chest CT scans) and breathing tests. You would also be enrolled in a long-term registry where researchers can follow your health through your medical records and periodic surveys. There is no medication being tested โ this is purely an observational study to gather information about how lung disease develops in newly diagnosed rheumatoid arthritis.
AI-generated summary from trial data ยท Jul 15, 2026 ยท Not medical advice
United States
Sponsor
University of Nebraska
Enrollment target
~125 participants
Started
March 2017
Primary completion
March 2029
Age range
19 Years โ 90 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Aimee B Schreiner, MS
University of Nebraska
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.